Danaher (NYSE:DHR) is scheduled to issue its quarterly earnings data before the market opens on Tuesday, January 30th. Analysts expect the company to announce earnings of $1.15 per share for the quarter.
Danaher (NYSE:DHR) opened at $99.97 on Tuesday. Danaher has a one year low of $78.97 and a one year high of $100.88. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. The firm has a market capitalization of $69,540.00, a price-to-earnings ratio of 29.75, a P/E/G ratio of 2.18 and a beta of 1.03.
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be paid a dividend of $0.14 per share. The ex-dividend date is Thursday, December 28th. This represents a $0.56 annualized dividend and a yield of 0.56%. Danaher’s dividend payout ratio (DPR) is 16.67%.
In other news, SVP Daniel Raskas sold 37,870 shares of the business’s stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $93.33, for a total value of $3,534,407.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the business’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $92.64, for a total value of $11,671,620.96. Following the completion of the transaction, the chief executive officer now directly owns 271,737 shares of the company’s stock, valued at approximately $25,173,715.68. The disclosure for this sale can be found here. Insiders own 12.20% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Danaher (DHR) Set to Announce Quarterly Earnings on Tuesday” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/01/23/danaher-dhr-set-to-announce-quarterly-earnings-on-tuesday.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.